Can the shingles vaccine stave off dementia?
A growing body of research suggests that some common vaccinations have benefits far beyond preventing the disease they were designed for.
Inside the Nebraska quarantine facility responding to hantavirus
The National Quarantine Unit in Nebraska is housing 18 people exposed to hantavirus, and preparing for possible cases of Ebola exposure.
How do clinical trials work, and who can participate?
A bioethicist walks us through the complexity of clinical trials, from their core scientific questions to patient selection to FDA approval.
Use of herbicide linked to Parkinson’s is on the rise in the US
A processing plant in Mississippi is leaking massive amounts of paraquat into the air. Its biological link to Parkinson’s is becoming clear.
How yawning might help clear dirty fluid from the brain
Research shows yawning might help clear waste from our brains. Plus, breaking down a CDC report on how little sleep Americans are getting.
Federal actions on vaccine research, vapes, and drug access
We’re rounding up a busy week in health policy news, following actions on vaccine research, fruit-flavored vapes, and abortion drug access.
Understanding the gynecological health crisis facing Black women
Black women face systemic issues accessing gynecological care. A physician-scientist outlines her vision to improve healthcare disparities.
Just had heart surgery? You might get the blues
Many cardiac patients experience sadness or anxiety after leaving the hospital. Being prepared for the “cardiac blues” can make a difference.
How do you study microplastics in a plastic-filled lab?
Measuring microplastics can be hard, partly because they’re everywhere—including the lab. One researcher is working on solutions.
What is ibogaine, and why is it in the news?
A recent executive order issued by President Trump aims to fast-track research for psychedelics, including ibogaine. What is it?